| Literature DB >> 29942497 |
Kittrawee Kritmetapak1, Sirirat Anutrakulchai1, Chatlert Pongchaiyakul2, Anucha Puapairoj3.
Abstract
BACKGROUND: Renal involvement in type 2 diabetes is mainly due to diabetic nephropathy (DN). Nevertheless, a sizable proportion of diabetic patients could actually have nondiabetic renal diseases (NDRDs) or DN plus NDRDs. This study aimed to explore the pathological features of NDRD in diabetic patients and to assess the predictability of diagnosing NDRD (±DN) versus isolated DN on the basis of clinical parameters.Entities:
Keywords: diabetic nephropathy; nondiabetic renal disease; renal biopsy; type 2 diabetes
Year: 2017 PMID: 29942497 PMCID: PMC6007236 DOI: 10.1093/ckj/sfx111
Source DB: PubMed Journal: Clin Kidney J ISSN: 2048-8505
Demographic and clinical characteristics of the study patients at the time of renal biopsy
| Characteristics | Isolated DN ( | Isolated NDRD ( | DN plus NDRD ( | P-value |
|---|---|---|---|---|
| Male sex, | 23 (44.2) | 13 (65) | 22 (75.9) | 0.017 |
| Age (years) | 51 ± 13 | 50 ± 7 | 53 ± 12 | 0.72 |
| Duration of diabetes (years) | 8.1 ± 4.8 | 3.8 ± 1.5 | 6.4 ± 3.1 | <0.001 |
| Presence of diabetic retinopathy, | 44 (84.6) | 3 (15) | 19 (65.5) | <0.001 |
| Systolic blood pressure (mmHg) | 149 ± 17 | 141 ± 10 | 149 ± 20 | 0.17 |
| Diastolic blood pressure (mmHg) | 81 ± 8 | 80 ± 4 | 83 ± 9 | 0.27 |
| Hemoglobin (g/dL) | 9.7 ± 1.5 | 10.4 ± 1.1 | 9.6 ± 1.5 | 0.16 |
| Fasting plasma glucose (mg/dL) | 183 ± 5.7 | 140 ± 6.7 | 164 ± 5.3 | 0.002 |
| HbA1c (%) | 8.5 ± 1.0 | 7.3 ± 0.1 | 8.1 ± 1.1 | <0.001 |
| Serum creatinine (mg/dL) | 2.69 ± 2.05 | 1.45 ± 0.50 | 3.90 ± 2.06 | <0.001 |
| eGFR | 38.2 ± 27.6 | 58.7 ± 23.9 | 31.8 ± 31.5 | 0.004 |
| Serum total cholesterol (mg/dL) | 300 ± 89 | 226 ± 42 | 249 ± 82 | 0.001 |
| Serum albumin (g/dL) | 2.8 ± 0.6 | 3.0 ± 0.4 | 2.7 ± 0.5 | 0.14 |
| Proteinuria (g/24 h) | 6.9 ± 3.2 | 3.5 ± 2.1 | 5.3 ± 3.5 | <0.001 |
| Urinary red blood cells/HPF | 2 ± 4 | 12 ± 9 | 7 ± 8 | <0.001 |
| Urinary white blood cells/HPF | 1 ± 1 | 8 ± 6 | 6 ± 11 | <0.001 |
HPF, high-power field.
Isolated DN versus DN plus NDRD (P < 0.05).
Isolated DN versus isolated NDRD (P < 0.05).
Isolated NDRD versus DN plus NDRD (P < 0.05).
The eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration Creatinine Equation.
Fig. 1.Indications for renal biopsy in the study patients.
Renal pathology of NDRD, with and without DN, in type 2 diabetes patients
| Histology | NDRD superimposed on DN ( | Isolated NDRD ( | P-value |
|---|---|---|---|
| Acute tubular necrosis | 14 (38.9) | 0 (0) | <0.001 |
| Acute interstitial nephritis | 12 (33.3) | 1 (5.0) | 0.007 |
| IgA nephropathy | 1 (2.8) | 7 (35.0) | 0.005 |
| Membranous nephropathy | 0 (0) | 5 (25.0) | 0.008 |
| Lupus nephritis | 2 (5.6) | 4 (20.0) | 0.21 |
| Crescentic glomerulonephritis | 3 (8.2) | 1 (5.0) | 0.64 |
| Membranoproliferative glomerulonephritis | 0 (0) | 1 (5.0) | 0.22 |
| Focal segmental glomerulosclerosis | 1 (2.8) | 0 (0) | 0.41 |
| IgM nephropathy | 2 (5.6) | 1 (5.0) | 1.00 |
| Chronic interstitial nephritis | 1 (2.8) | 0 (0) | 1.00 |
Values are presented as n (%).
Some patients have more than one renal pathology.
Multivariate analysis of clinical parameters in patients with NDRD with or without DN
| Variables | OR | 95% CI | P-value |
|---|---|---|---|
| Male gender | 4.43 | 1.39–14.15 | 0.01 |
| Duration of diabetes (>8 years) | 0.15 | 0.04–0.49 | 0.002 |
| Glycated hemoglobin (HbA1c) | 0.16 | 0.05–0.47 | 0.001 |
| Active urinary sediment | 4.75 | 1.46–15.43 | 0.01 |
Active urinary sediment is defined as 10 or more red and white blood cells per high-power field.